184 related articles for article (PubMed ID: 16133963)
1. Low direct cytotoxicity of nabumetone on gastric mucosal cells.
Arai Y; Tanaka K; Ushijima H; Tomisato W; Tsutsumi S; Aburaya M; Hoshino T; Yokomizo K; Suzuki K; Katsu T; Tsuchiya T; Mizushima T
Dig Dis Sci; 2005 Sep; 50(9):1641-6. PubMed ID: 16133963
[TBL] [Abstract][Full Text] [Related]
2. Low direct cytotoxicity of loxoprofen on gastric mucosal cells.
Yamakawa N; Suemasu S; Kimoto A; Arai Y; Ishihara T; Yokomizo K; Okamoto Y; Otsuka M; Tanaka K; Mizushima T
Biol Pharm Bull; 2010; 33(3):398-403. PubMed ID: 20190399
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Agents Actions; 1992; Spec No():C82-3. PubMed ID: 1442340
[TBL] [Abstract][Full Text] [Related]
4. Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Dig Dis Sci; 1992 Dec; 37(12):1847-52. PubMed ID: 1473433
[TBL] [Abstract][Full Text] [Related]
5. The in vitro effects of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone, on rat gastric mucosal eicosanoid synthesis and metabolism.
Melarange R; Spangler R; Hoult JR
Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):195-200. PubMed ID: 8931119
[TBL] [Abstract][Full Text] [Related]
6. Effects of NSAIDs on cryoprobe-induced gastric ulcer healing in rats.
Tibble J; Sigthorsson G; Caldwell C; Palmer RH; Bjarnason I
Aliment Pharmacol Ther; 2001 Dec; 15(12):2001-8. PubMed ID: 11736732
[TBL] [Abstract][Full Text] [Related]
7. Effect of the antiinflammatory prodrug, nabumetone and its principal active metabolite on rat gastric mucosal, aortic and platelet eicosanoid synthesis, in vitro and ex vivo.
Jeremy JY; Thompson CS; Mikhailidis DP; Dandona P
Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):195-9. PubMed ID: 2281122
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drug, nabumetone, prevents indometacin-induced gastric damage via inhibition of neutrophil functions.
Ishiwata Y; Okamoto M; Yokochi S; Hashimoto H; Nakamura T; Miyachi A; Naito Y; Yoshikawa T
J Pharm Pharmacol; 2003 Feb; 55(2):229-37. PubMed ID: 12635655
[TBL] [Abstract][Full Text] [Related]
9. The effect of nabumetone and its principal active metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function.
Jeremy JY; Mikhailidis DP; Barradas MA; Kirk RM; Dandona P
Br J Rheumatol; 1990 Apr; 29(2):116-9. PubMed ID: 2108782
[TBL] [Abstract][Full Text] [Related]
10. The unique pharmacologic profile of nabumetone.
Blower PR
J Rheumatol Suppl; 1992 Nov; 36():13-9. PubMed ID: 1474529
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution?
Dandona P; Jeremy JY
Drugs; 1990; 40 Suppl 5():16-24. PubMed ID: 2081487
[TBL] [Abstract][Full Text] [Related]
12. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
Friedel HA; Langtry HD; Buckley MM
Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
[TBL] [Abstract][Full Text] [Related]
13. Low direct cytotoxicity and cytoprotective effects of nitric oxide releasing indomethacin.
Tomisato W; Tanaka K; Tsutsumi S; Hoshino T; Yokomizo K; Suzuki K; Katsu T; Mizushima T; Mizushima T
Dig Dis Sci; 2005 Oct; 50(10):1927-37. PubMed ID: 16187199
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of nabumetone with indomethacin on rat gastric mucosal 6-keto-PGF1 alpha production and on bile salt-induced changes in gastric mucosal function.
Melarange R; Rashbrook LC
J Pharm Pharmacol; 1987 Sep; 39(9):717-20. PubMed ID: 2445949
[TBL] [Abstract][Full Text] [Related]
15. Disposition and excretion of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone in horses.
Soma LR; Uboh CE; Rudy JA; Smith MS
Am J Vet Res; 1996 Apr; 57(4):517-21. PubMed ID: 8712517
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis.
Ishihara T; Tanaka K; Tashiro S; Yoshida K; Mizushima T
Biochem Pharmacol; 2010 Jun; 79(11):1622-33. PubMed ID: 20132796
[TBL] [Abstract][Full Text] [Related]
17. [Gastrointestinal damage induced by celecoxib and rofecoxib in rats].
Laudanno OM; Cesolari JA; Esnarriaga J; Rista L; Piombo G; Maglione C; Aramberry LJ; Sambrano JS; Godoy A; Rocaspana A
Acta Gastroenterol Latinoam; 2000; 30(1):27-33. PubMed ID: 10855352
[TBL] [Abstract][Full Text] [Related]
18. Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability.
Bannwarth B
Drug Saf; 2008; 31(6):485-503. PubMed ID: 18484783
[TBL] [Abstract][Full Text] [Related]
19. Effects of the prodrug nabumetone, and its active metabolite, 6-MNA, on human and rat gastric mucosal prostanoids and platelet function.
Jeremy JY; Mikhailidis DP; Barradas MA; Kirk RM; Dandona P
Drugs; 1990; 40 Suppl 5():53-6. PubMed ID: 2081494
[No Abstract] [Full Text] [Related]
20. Heme oxygenase-1 protects gastric mucosal cells against non-steroidal anti-inflammatory drugs.
Aburaya M; Tanaka K; Hoshino T; Tsutsumi S; Suzuki K; Makise M; Akagi R; Mizushima T
J Biol Chem; 2006 Nov; 281(44):33422-32. PubMed ID: 16945925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
